Adult T-cell leukemia/lymphoma (ATLL) in Japan presents at a median age of 70 years and
only 5% of patients are< 50 years of age. We conducted RNA and targeted DNA sequencing …

Simple Summary In this review paper, we aim to summarize recent findings of genomic
alterations found in adult T-cell leukemia/lymphoma (ATLL), which is an incurable disease …

The prognosis of patients with aggressive adult T cell leukemia–lymphoma (ATLL) is dismal
even with intensive chemotherapy. Allogeneic hematopoietic stem cell transplantation …

Acute or lymphomatous type adult T cell leukemia/lymphoma (ATLL) is an aggressive
hematopoietic malignancy with poor prognosis. We previously reported that programmed …

Adult T-cell leukemia/lymphoma (ATLL) is caused by the HTLV-1 virus, endemic to Japan
and the Caribbean, and is likely derived from cells with the T-regulatory phenotype. The …

Adult T-cell leukemia lymphoma (ATLL) is a rare T cell neoplasm that is endemic in
Japanese, Caribbean, and Latin American populations. Most North American ATLL patients …

Adult T-cell leukemia/lymphoma (ATLL) is a peripheral T-cell neoplasm of highly
pleomorphic lymphoid cells. ATLL is usually widely disseminated, and it is caused by human …

Adult T‐cell leukemia/lymphoma (ATL) is a peripheral T‐cell neoplasm with a dismal
prognosis. It is caused by human T‐cell leukemia virus type‐1 (HTLV‐1) retrovirus. A long …

Adult T cell leukemia/lymphoma (ATL) is a peripheral T cell neoplasm of largely unknown
genetic basis, associated with human T cell leukemia virus type-1 (HTLV-1) infection. Here …

Adult T-cell leukemia-lymphoma (ATLL) is caused by HTLV-I, and is a disease with dismal
prognosis urging new therapies. Brentuximab vedotin (SGN-35) is an anti-CD30 monoclonal …